SS Innovations International Inc. SSII Archives

FridayOct 02, 2026 2:27 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra for Next Phase of Expansion

SS Innovations International (NASDAQ: SSII) is expanding its SSi Mantra surgical robotic platform from an established base in India into international markets, with growth reflected in both revenue and system installations. Second-quarter revenue increased 39.4% year over year to $13.9 million, while the company installed 30 systems during the quarter, bringing its total installed base to 224 systems across 12 countries and more than 12,000 cumulative procedures as of June 30, 2026. The company supports a range of specialties, including cardiac, urology, gynecology, general and thoracic surgery, and is also developing telesurgery capabilities. SSII’s growth opportunity extends beyond its current…

FridaySep 25, 2026 3:38 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Eyes Growing Opportunity for Surgical Robotics

SS Innovations International (NASDAQ: SSII) is building momentum for its SSi Mantra surgical robotic system, with growing utilization in India providing a foundation for broader international expansion. More than 50 robotic procedures were performed with the system in a single day at Mohak Bariatrics and Robotics in Indore, while the company reported 224 SSi Mantra systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during the second quarter of 2026. Quarterly revenue rose 39% to $13.9 million, with system sales increasing 41% to $12.4 million, while installations reached 30 systems during the quarter. India remains the…

ThursdaySep 24, 2026 11:15 am

SS Innovations International Inc. (NASDAQ: SSII) Expands Robotic Cardiac Surgery Footprint with New Program at HCG Hospital in Ahmedabad

The program began with a robotic left internal mammary artery (“LIMA”) take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra advanced robotic surgical system from SS Innovations. SS Innovations reported 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025. The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka and the Philippines. SS Innovations is pursuing U.S. FDA review and European Union CE marking as it seeks to expand SSi Mantra into additional international markets. SS Innovations International (NASDAQ: SSII), a…

ThursdaySep 17, 2026 3:08 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Positions SSi Mantra Amidst Expanding MedTech Market

SS Innovations International (NASDAQ: SSII) is eying opportunity as India seeks to grow domestic manufacturing and reduce reliance on imported medical technology. The market is projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, while government initiatives aim to strengthen the medical-device manufacturing ecosystem and increase its global market share. SS Innovations already has an established base with its proprietary SSi Mantra surgical robotic system, reporting 224 installations across 12 countries by June 30, 2026, with those systems used in more than 12,000 surgeries. The company also reported strong first-half 2026 financials, including 65.6% year-over-year revenue…

WednesdaySep 16, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Expands Global Footprint as SSi Mantra Procedures Reach 14,103

The company reported continued growth of its SSi Mantra surgical robotic system, with installations reaching 238 as of September 8, 2026, with the installed base now spanning 12 countries, following recent launches in Colombia and Sri Lanka and further international expansion. The company said cumulative SSi Mantra procedures reached 14,103, a 79% increase from 7,885 at the end of 2025. Pediatric applications continue to expand, including a robotic kidney procedure performed on a 45-day-old infant in India using 5-millimeter instruments. SS Innovations reported 188 cumulative robotic telesurgeries as of August 31, alongside long-distance procedures connecting surgeons and patients across countries.…

ThursdaySep 10, 2026 11:15 am

SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka

The company has supported the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted LIMA takedown, performed by SS Innovations founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. Kings Hospital has completed more than 25 robotic procedures in three weeks, according to a recent company video describing the program’s early activity. SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company’s second-quarter revenue reached $13.9 million,…

ThursdaySep 10, 2026 9:50 am

QualityStocksNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach

SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across 12 countries, approximately 1,500 physicians have been trained on the platform and the system has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, installation of the first SSi Mantra in Sri…

FridaySep 04, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Is Turning India’s Surgical Robotics Opportunity Into a Global Growth Story

SS Innovations is scaling its SSi Mantra surgical robotic system from an established Indian base into international markets. Second-quarter revenue rose 39.4% year over year to $13.9 million, while 30 SSi Mantra systems were installed during the quarter. The company entered the second half of 2026 with 224 systems installed across 12 countries and more than 12,000 cumulative procedures. Potential regulatory clearance in the United States and CE marking in Europe could materially enlarge SSII’s addressable market. The investment case is seen as attractive because SSII is still early in its commercialization curve, although investors must weigh cash consumption, regulatory…

TuesdaySep 01, 2026 12:40 pm

QualityStocksNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Highlighted as Stronger Growth Opportunity in Seeking Alpha Analysis

SS Innovations International (NASDAQ: SSII) was highlighted in a Seeking Alpha analysis comparing the company with Intuitive Surgical, Inc. (NASDAQ: ISRG) in the expanding surgical robotics market. The analysis cited SS Innovations growth trajectory, emerging-market positioning and lower-cost SSi Mantra surgical robotic platform, noting that its installed base increased 187% from 78 systems at the end of Q1 FY25 to 224 in Q2 FY26, while Q2 revenue increased 39% year over year. The author identified potential U.S. and European regulatory milestones as key near-term catalysts, with feedback on the company FDA 510(k) premarket notification expected by the end of Q1…

FridayAug 28, 2026 9:00 am

SS Innovations International Inc. (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity

SS Innovation’s SSi Mantra system was used in more than 50 robotic surgeries in a single day at Mohak Bariatrics and Robotics in Indore, highlighting growing clinical utilization in India. The milestone comes as SS Innovations reports 224 SSi Mantra systems installed across 12 countries, providing a growing installed base for future procedure and instrument revenue. Second-quarter 2026 installations reached 30 systems, above the 25 systems modeled by the analyst cited in the supplied report. Quarterly revenue reached $13.9 million, up 39% year over year, while system sales increased 41% to $12.4 million. FDA review of the SSi Mantra 510(k)…

Site Search

Company Search

Tag: SS Innovations International Inc. SSII